Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief ...

The company reported adjusted earnings per share of $0.28 on revenue of $586 million – a significant rise compared to last ...

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the ...

Hims & Hers Health, Inc. (HIMS) shares soared 23% in the last trading session to close at $35.04. The move was backed by solid volume with far more shares changing hands than in a normal session.

Online telehealth companies like Hims & Hers and Ro, better known for sale of erectile disfunction and hair loss drugs, were able to sell copycats as self-pay drugs at huge discounts while ...

Scottie Scheffler, Amanda Balionis Interview Turns Heads After Historic Win Warren Buffett sends strong message on stock market drop Chain Sandwich Shops Ranked From Worst To Best Pritzker and ...

In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions, with plans starting at $599 a month. The offering will launch this ...

Novo Nordisk A/S is partnering with telehealth companies including Hims & Hers Health Inc., LifeMD Inc., and Ro to offer weight-loss drug Wegovy at lower price. Novo Nordisk A/S is partnering with ...

Shares of Hims & Hers Health (NYSE: HIMS) and LifeMD (NASDAQ: LFMD) are surging on Tuesday. The companie' stocks had jumped 24% and 34%, respectively, as of 3:15 p.m. ET as the S&P 500 and the ...

The providers -- Hims & Hers Health, Ro, and LifeMD -- will be shipping the weight-loss medication to patients’ homes. Patients who don’t have health insurance coverage for the weekly ...

Shelby Knowles / Bloomberg / Getty Images Hims & Hers Health shares surged Tuesday as the company announced a partnership with Danish drugmaker Novo Nordisk. Hims & Hers users will have access to ...